 Association therapy staphylococcal bacteremia authors patients undergoing leukapheresis peripheral stem cell harvesting PSCH lymphokine killer LAK cell generation weeks catheter placement evidence local systemic infections period patients underwent leukapheresis PSCH preparation autologous bone marrow transplantation ABMT original catheters place average days documented infections Seventeen patients underwent leukapheresis part low-dose treatment LAK cell generation catheters place average days episodes bacteremia patients high-dose underwent leukapheresis LAK cell generation catheters place average days episodes bacteremia cases bacteremia Staphylococcus species blood exposure level risk bacteremia Other potential risk factors number pheresis procedures complement level serum immunoglobulin levels absolute count risk